These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38635256)

  • 1. A challenging case of mast cell sarcoma primarily involving the bone marrow.
    Abi-Saab T; Matkovic E
    Blood; 2024 Apr; 143(16):1676. PubMed ID: 38635256
    [No Abstract]   [Full Text] [Related]  

  • 2. [Association of bone marrow mastocytosis with extremely immature extramedullary mast cell sarcoma].
    Sotlar K; Horny HP; Lebherz J; Leser HG; Bültmann B
    Pathologe; 1997 May; 18(3):252-6. PubMed ID: 9273545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplastic mast cell sarcoma: a unique pathologic entity in mastocytosis.
    He F; Horny HP; Boone J; Raza A; Griffith M; Hurley P; Dolan M; Cayci Z; Linden MA; McKenna R; Ustun C
    Leuk Lymphoma; 2017 Jun; 58(6):1515-1517. PubMed ID: 27808598
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mast cells in the peripheral blood as a presenting form of malignant mastocytosis].
    García Erce J; Vicente Cámara P; Aguilar Franco C; Alvarez Alegret R; Soria Santeodoro MT
    Sangre (Barc); 1997 Feb; 42(1):89-90. PubMed ID: 9229815
    [No Abstract]   [Full Text] [Related]  

  • 5. [Case of systemic mastocytosis].
    Szeloch U; Jastrzebska D; Kujawski J
    Przegl Dermatol; 1973; 60(3):365-9. PubMed ID: 4201194
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated H-Ras.
    Guo X; Schrader KA; Xu Y; Schrader JW
    Oncogene; 2005 Mar; 24(14):2330-42. PubMed ID: 15735740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant mastocytosis and myelodysplastic syndrome.
    Dash S; Rao NR; Deodhar SD; Varma N
    Br J Haematol; 1991 Nov; 79(3):530-1. PubMed ID: 1751386
    [No Abstract]   [Full Text] [Related]  

  • 8. Mast cell sarcoma: clinical management.
    Weiler CR; Butterfield J
    Immunol Allergy Clin North Am; 2014 May; 34(2):423-32. PubMed ID: 24745684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell sarcoma: new cases and literature review.
    Monnier J; Georgin-Lavialle S; Canioni D; Lhermitte L; Soussan M; Arock M; Bruneau J; Dubreuil P; Bodemer C; Chandesris MO; Lortholary O; Hermine O; Damaj G
    Oncotarget; 2016 Oct; 7(40):66299-66309. PubMed ID: 27602777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell sarcoma of the larynx.
    Horny HP; Parwaresch MR; Kaiserling E; Müller K; Olbermann M; Mainzer K; Lennert K
    J Clin Pathol; 1986 Jun; 39(6):596-602. PubMed ID: 3088063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic mastocytosis and mastocytemia in a cat.
    Weller RE
    Mod Vet Pract; 1978 Jan; 59(1):41-3. PubMed ID: 415220
    [No Abstract]   [Full Text] [Related]  

  • 12. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI.
    Kirshenbaum AS; Akin C; Wu Y; Rottem M; Goff JP; Beaven MA; Rao VK; Metcalfe DD
    Leuk Res; 2003 Aug; 27(8):677-82. PubMed ID: 12801524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive mast cell leukemia/sarcoma with CD4 expression and hemophagocytosis.
    Heimes Dillon AL; Kelting SM
    Blood; 2023 Mar; 141(11):1364. PubMed ID: 36929432
    [No Abstract]   [Full Text] [Related]  

  • 15. The first report of human primary thoracic spine mast cell sarcoma: a case report.
    Ravanpay AC; Fromm JR; Edlefsen KL; Martin P; Chesnut R
    Clin Neuropathol; 2018; 37(1):28-35. PubMed ID: 28992848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications.
    Ryan RJ; Akin C; Castells M; Wills M; Selig MK; Nielsen GP; Ferry JA; Hornick JL
    Mod Pathol; 2013 Apr; 26(4):533-43. PubMed ID: 23196796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis.
    Sperr WR; Escribano L; Jordan JH; Schernthaner GH; Kundi M; Horny HP; Valent P
    Leuk Res; 2001 Jul; 25(7):529-36. PubMed ID: 11377677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant mastocytosis with circulating mast cells.
    Torrey E; Simpson K; Wilbur S; Munoz P; Skikne B
    Am J Hematol; 1990 Aug; 34(4):283-6. PubMed ID: 2114786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic report of 29 necropsies on dogs with mastocytoma.
    Hottendorf GH; Nielsen SW
    Pathol Vet; 1968; 5(2):102-21. PubMed ID: 4970397
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
    Beghini A; Cairoli R; Morra E; Larizza L
    Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.